All Type of News
Bayer’s labor union begins limitless one-person protestThe Bayer’s labor union has begun a no-time-limit one-person protest over the recommended resignation of the 3 team managers in the women health department.
Since the company h...
|
Patients’ organization, “Harvoni requires the national insurance benefit promptly”
The Korea Alliance of Patients Organization insisted application of the national health insurance benefit on ‘Harvoni,’ a hepatitis C treatment.
The organization announced victims of the Dana Clinical from hepatitis ...
Short supply of Terramycin exposes weak spot of the pharmaceutical notification system
“If a top product of a specific prescription market is not supplied for a year, it must be considered not as out-of-stock, but manufacturing suspension.”
It is a part of the opinions towards the short supply of Pfize...
77 pharmaceutical products including multinational ones liquidates 531 products
Multinational pharmaceutical companies, as well as domestic ones, have decided to voluntarily liquidate pharmaceutical products weakened in market competitiveness.
According to the Ministry of Food and Drug Safety, 7...
CEOs of domestic pharmaceutical companies left to the U.S., “To become the next Hanmi”
CEOs and researchers of major domestic pharmaceutical companies left the country to participate in the J.P. Morgan Healthcare Conference which will be held for five days between the 11th and 14th in San Francisco.
Al...
AZ rejected on the Seroquel’s flexible application of PMS cases for children
The flexible application of the post-marketing surveillance(PMS) for the AstraZeneca’s schizophrenia treatment, ‘Seroquel(generic name: quetiapine),’ was rejected. The issue was the number of cases targeting children ...
Dong-A Pharm’s Bacchus exceeds KRW 200 billion annual sales as single productCreating a term, ‘Bacchus Legend,’ Dong-A Pharm(President and CEO Won-hee Lee) announced on the 11th that the domestic sales of ‘Bacchus,’ which has become the leading energy dr...
|
Handok establishes partnership agreement with U.S. BrukerHandok(President Young-jin Kim) established a partnership agreement with Bruker, a company specializing in global mass spectrometers. Under the term of the agreement, the Handok...
|
Supreme Court decides the patent suit of Lyrica on 14th
The final decision of the patent suit for the use patent of the Lyrica(Pfizer), a large-scale painkiller, will be made on the 14th.
The Supreme Court will announce the decision on the action of nullity of the Lyrica’...
Late entry of ‘Original’ Sanofi in the Plavix complex market
The original company has made a move. Sanofi, the developing company of ‘Plavix,’ is planning to enter the ‘aspirin’ complex market.
According to the industry concerned on the 11th, Sanofi-Aventis Korea is working on...
